Elevated circulating Krüppel-like factor 4 level as a novel independent marker of the proatherogenic risk in patients with psoriasis: a preliminary study

Anna Baran; Julita A. Krahel; Tomasz Kaminski; Magdalena Krawiel; Magdalena Maciaszek; Iwona Flisiak

doi:10.5114/ada.2020.98560

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

6/2021
vol. 38

Send email

Copy url:

abstract:

Original paper

Elevated circulating Krüppel-like factor 4 level as a novel independent marker of the proatherogenic risk in patients with psoriasis: a preliminary study

Anna Baran

¹

,

Julita A. Krahel

¹

,

Tomasz W. Kaminski

²

,

Magdalena Krawiel

¹

,

Magdalena Maciaszek

³

,

Iwona Flisiak

¹

Department of Dermatology and Venereology, Medical University of Bialystok, Bialystok, Poland
Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, USA
Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland

Adv Dermatol Allergol 2021; XXXVIII (6): 1023–1031

DOI: https://doi.org/10.5114/ada.2020.98560

Online publish date: 2020/09/02

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Baran A, Krahel J, Kaminski TW, Krawiel M, Maciaszek M, Flisiak I. Elevated circulating Krüppel-like factor 4 level as a novel independent marker of the proatherogenic risk in patients with psoriasis: a preliminary study. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2021;38(6):1023-1032. doi:10.5114/ada.2020.98560.

APA

Baran, A., Krahel, J., Kaminski, T. W., Krawiel, M., Maciaszek, M.,  & Flisiak, I. (2021). Elevated circulating Krüppel-like factor 4 level as a novel independent marker of the proatherogenic risk in patients with psoriasis: a preliminary study. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 38(6), 1023-1032. https://doi.org/10.5114/ada.2020.98560

Chicago

Baran, Anna, Julita A. Krahel, Tomasz W Kaminski, Magdalena Krawiel, Magdalena Maciaszek,  and Iwona Flisiak. 2021. "Elevated circulating Krüppel-like factor 4 level as a novel independent marker of the proatherogenic risk in patients with psoriasis: a preliminary study". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 38 (6): 1023-1032. doi:10.5114/ada.2020.98560.

Harvard

Baran, A., Krahel, J., Kaminski, T., Krawiel, M., Maciaszek, M.,  and Flisiak, I. (2021). Elevated circulating Krüppel-like factor 4 level as a novel independent marker of the proatherogenic risk in patients with psoriasis: a preliminary study. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 38(6), pp.1023-1032. https://doi.org/10.5114/ada.2020.98560

MLA

Baran, Anna et al. "Elevated circulating Krüppel-like factor 4 level as a novel independent marker of the proatherogenic risk in patients with psoriasis: a preliminary study." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 38, no. 6, 2021, pp. 1023-1032. doi:10.5114/ada.2020.98560.

Vancouver

Baran A, Krahel J, Kaminski T, Krawiel M, Maciaszek M, Flisiak I. Elevated circulating Krüppel-like factor 4 level as a novel independent marker of the proatherogenic risk in patients with psoriasis: a preliminary study. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2021;38(6):1023-1032. doi:10.5114/ada.2020.98560.

Introduction
Krüppel-like factor 4 (KLF4) is a transcription factor of anti-inflammatory and anti-thrombotic properties not studied in psoriasis yet.

Aim
To analyze the clinical value of the serum KLF4 level in psoriatics and elucidate the interplay between disease activity, metabolic or inflammatory parameters and systemic therapy.

Material and methods
The study enrolled thirty-four psoriatics and fifteen healthy subjects. Blood samples were collected before and after twelve weeks of treatment with methotrexate or acitretin. Serum KLF4 levels were measured using immune-enzymatic method.

Results
Serum KLF4 levels in psoriatic patients did not statistically differ comparing to the controls (p > 0.05). However, in severe psoriasis, KLF4 was significantly higher than in healthy ones before treatment and normalized after treatment to baseline levels of controls (p < 0.05, p > 0.05, respectively). KLF4 positively correlated with body mass index (p = 0.038) but not with psoriasis severity, nor inflammatory or metabolic markers. Interestingly, many pro-atherogenic parameters were shown as variables independently predicting the levels of KLF4. No significant effect of three-month systemic treatment on KLF4 was found.

Conclusions
KLF4 may be a novel independent indicator of the proatherogenic risk in psoriatics, especially with a severe form or obesity.

keywords:

Elevated circulating Krüppel-like factor 4 level as a novel independent marker of the proatherogenic risk in patients with psoriasis: a preliminary study

Anna Baran 1 , Julita A. Krahel 1 , Tomasz W. Kaminski 2 , Magdalena Krawiel 1 , Magdalena Maciaszek 3 , Iwona Flisiak 1

psoriasis, Krüppel-like factor 4, proatherogenic risk, antipsoriatic treatment

Anna Baran

¹

,

Julita A. Krahel

¹

,

Tomasz W. Kaminski

²

,

Magdalena Krawiel

¹

,

Magdalena Maciaszek

³

,

Iwona Flisiak

¹